STB
SRNE

S&T Bank’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

S&T Bank’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-38,853
Closed -$14K – 103
2023
Q1 		$14K Hold
38,853
– – ﹤0.01% 100
2022
Q4 		$34K Hold
38,853
– – 0.01% 109
2022
Q3 		$61K Hold
38,853
– – 0.01% 109
2022
Q2 		$78K Hold
38,853
– – 0.01% 123
2022
Q1 		$91K Hold
38,853
– – 0.01% 130
2021
Q4 		$181K Hold
38,853
– – 0.03% 136
2021
Q3 		$296K Hold
38,853
– – 0.05% 119
2021
Q2 		$376K Hold
38,853
– – 0.06% 109
2021
Q1 		$321K Hold
38,853
– – 0.05% 114
2020
Q4 		$265K Hold
38,853
– – 0.05% 117
2020
Q3 		$433K Hold
38,853
– – 0.1% 87
2020
Q2 		$244K Hold
38,853
– – 0.06% 101
2020
Q1 		$71K Buy
38,853
+10,683
+38% +$30.8K 0.02% 97
2019
Q4 		$95K Buy
+28,170
New +$67.2K 0.02% 94

Other funds holding SRNE

SW
SlateStone Wealth Jupiter, Florida $1.21B AUM 21.86% 1-Year Est. Return
KA
KLCM Advisors Milwaukee, Wisconsin $1.15B AUM 34.45% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
AA
AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return
OAJ
Ogorek Anthony Joseph Williamsville, New York $365M AUM 18.21% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
CFGS
Concourse Financial Group Securities Birmingham, Alabama $1.77B AUM 17.37% 1-Year Est. Return